The Latest Breaking News on Pharma

AstraZeneca drops plans for Covid jab approval in US

The drugs giant will instead focus its Covid-19 vaccine efforts elsewhere globally and for its use as a booster.

The Independent UK · Nov 10, 2022

High-risk groups top priority for 2023 Covid jabs

Authorities plan to acquire enough Covid-19 vaccines next year initially for 18 million people in high-risk groups, with the number of shots each person will need subject to World Health Organization (WHO) guidance.

Bangkok Post · Nov 10, 2022

Is cannabis an effective antibiotic?

Cannabis-based drugs like CBD and THC show surprising potential for defeating antibiotic-resistant germs

Salon · Nov 10, 2022

Who can get an autumn Covid booster jab and how do I book?

Booster vaccinations are being offered to everyone in England over the age of 50

The Independent UK · Nov 10, 2022

Health department says fifth COVID-19 vaccine doses not being recommended for most people amid rising cases

The Department of Health says fifth doses of a COVID-19 vaccine are not currently being recommended for most people.

ABC News · Nov 10, 2022

Dutch, UK fentanyl sellers hit with Treasury sanctions

Two Dutch nationals, an Englishman and nine companies have been targeted for sanctions by the U.S. government for allegedly operating an illegal fentanyl ring that generated millions of dollars in virtual currency

The Independent UK · Nov 9, 2022

Parents urged to support research aimed at protecting babies from RSV infections

Respiratory Syncytial Virus is the leading cause of infant hospital admissions in the UK.

The Independent UK · Nov 9, 2022

Is This Biotech Stock a Rising Star in the Making?

Shares of oncology-focused biotechnology company Sonnet BioTherapeutics (SONN) have plummeted more than 70% in price year-to-date due to its poor financials and the broad-based market sell-off. However, the company is advancing its drug candidates via research breakthroughs, clinical trials, and strategic initiatives. Given the company’s constant progress, can this biotech…

StockNews.com · Nov 9, 2022

EXCLUSIVE: New Partnership Brings Leading Psychedelic Protocol For Alcoholism Treatment To NYC

NYC-based clinics brand Nushama has partnered with Awakn Life Sciences (OTCQB: AWKNF), a clinical-stage psychedelics biotech company to bring

Benzinga · Nov 9, 2022

Inhalable and nasal Covid vaccines could trump regular shots

We need to consider a vaccine strategy that will provide longer-term immunity

Wales Online · Nov 9, 2022